{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1470666", "DateCompleted": {"Year": "1993", "Month": "01", "Day": "27"}, "DateRevised": {"Year": "2007", "Month": "11", "Day": "14"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0032-0943", "JournalIssue": {"Volume": "58", "Issue": "5", "PubDate": {"Year": "1992", "Month": "Oct"}}, "Title": "Planta medica", "ISOAbbreviation": "Planta Med"}, "ArticleTitle": "Cytotoxic activity of cardenolides from Beaumontia brevituba stems.", "Pagination": {"StartPage": "429", "EndPage": "431", "MedlinePgn": "429-31"}, "Abstract": {"AbstractText": ["Five known cardenolides, digitoxigenin (1), oleandrigenin (2), digitoxigenin alpha-L-cymaroside (3), digitoxigenin beta-gentiobiosyl-alpha-L-cymaroside (4), and delta 16-digitoxigenin beta-D-glucosyl-alpha-L-cymaroside (5), were isolated from the stems of Beaumontia brevituba Oliver by cytotoxicity-directed fractionation monitored by a cultured human lung cancer cell line. The cytotoxic activity of these compounds was evaluated with a panel of twelve human and murine cancer cell lines. The lignan glycoside, syringaresinol beta-D-glucoside, was obtained for the first time in the form of its levo-enantiomer."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois, Chicago 60612."}], "LastName": "Kaneda", "ForeName": "N", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Chai", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Pezzuto", "ForeName": "J M", "Initials": "JM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kinghorn", "ForeName": "A D", "Initials": "AD"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Farnsworth", "ForeName": "N R", "Initials": "NR"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Tuchinda", "ForeName": "P", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Udchachon", "ForeName": "J", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Santisuk", "ForeName": "T", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Reutrakul", "ForeName": "V", "Initials": "V"}], "GrantList": [{"GrantID": "R01 CA33047", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Planta Med", "NlmUniqueID": "0066751", "ISSNLinking": "0032-0943"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Cardenolides"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cardenolides"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1992", "Month": "10", "Day": "1"}, {"Year": "1992", "Month": "10", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1992", "Month": "10", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1470666", "10.1055/s-2006-961506"]}}]}